article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

article thumbnail

Is the launch environment really more competitive now?

pharmaphorum

It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patient Acquisition as a Competitive Advantage

Penrod

By approaching the intake experience as a competitive advantage, you will attract more patients, decrease patient leakage, and drive more revenue. Let’s explore how to make your intake process a competitive advantage. By incorporating these three features, your intake process will give you a competitive advantage.

article thumbnail

Ethical Considerations in Medical Sales: Maintaining Integrity in a Competitive Industry

Rep-Lite

While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. The post Ethical Considerations in Medical Sales: Maintaining Integrity in a Competitive Industry appeared first on Medical Staffing & Recruitment Agency.

Ethics 52
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks.

article thumbnail

Sanofi drops out of competitive breast cancer drug race after another trial failure

MedCity News

Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule. The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.

article thumbnail

Personalization In Sales Leads To Increased Loyalty and Repeat Business

Integrity Solutions

It provides competitive differentiation, nurtures customer relationships, helps them feel seen and heard , and ultimately leads to increased customer loyalty and repeat business. Always lead with compassion and empathy. The research also shows 61% of customers feel they’re treated as a number rather than a human being.

Sales 107